Usher's Syndrome
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B (NCT02065011) | Sanofi | 2013-09-12 |
Track Usher's Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.